Page last updated: 2024-09-04

febuxostat and Cardiomyopathies, Primary

febuxostat has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kamatani, N; Kushiyama, A; Toyo-Oka, L; Toyo-Oka, T	1

Other Studies

1 other study(ies) available for febuxostat and Cardiomyopathies, Primary

Article	Year
Treatment of two mitochondrial disease patients with a combination of febuxostat and inosine that enhances cellular ATP. Journal of human genetics, 2019, Volume: 64, Issue:4 Topics: Adenosine Triphosphate; Aged, 80 and over; Cardiomyopathies; Diabetes Mellitus; Febuxostat; Female; Humans; Hypoxanthine; Inosine; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Natriuretic Peptide, Brain; Reactive Oxygen Species	2019

Article

Year

Treatment of two mitochondrial disease patients with a combination of febuxostat and inosine that enhances cellular ATP.

Journal of human genetics, 2019, Volume: 64, Issue:4

Topics: Adenosine Triphosphate; Aged, 80 and over; Cardiomyopathies; Diabetes Mellitus; Febuxostat; Female; Humans; Hypoxanthine; Inosine; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Natriuretic Peptide, Brain; Reactive Oxygen Species

2019